Advertisement
U.S. markets open in 8 hours 13 minutes

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed Price. Currency in USD
333.43-0.08 (-0.02%)
At close: 04:00PM EDT
333.43 0.00 (0.00%)
After hours: 05:48PM EDT
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,671,262
2,671,262
2,802,249
2,922,545
2,545,626
Cost of Revenue
1,244,316
1,244,316
1,234,919
1,284,449
1,107,739
Gross Profit
1,426,946
1,426,946
1,567,330
1,638,096
1,437,887
Operating Expense
1,089,150
1,089,150
1,092,214
1,137,760
1,016,561
Operating Income
337,796
337,796
475,116
500,336
421,326
Net Non Operating Interest Income Expense
51,461
51,461
19,886
17,349
-3,661
Other Income Expense
-1,239,404
-1,239,404
-5,199,249
4,931,395
4,500,354
Pretax Income
-850,104
-850,104
-4,704,273
5,449,055
4,918,007
Tax Provision
-212,780
-212,780
-1,076,738
1,194,798
1,103,778
Net Income Common Stockholders
-637,324
-637,324
-3,627,535
4,254,257
3,814,229
Diluted NI Available to Com Stockholders
-637,324
-637,324
-3,627,535
4,254,257
3,814,229
Basic EPS
-6.01
-21.82
-121.79
142.61
128.13
Diluted EPS
-6.01
-21.82
-121.79
140.83
126.47
Basic Average Shares
29,433
29,209
29,785
29,831
29,768
Diluted Average Shares
29,433
29,209
29,785
30,208
30,160
Total Operating Income as Reported
337,796
337,796
482,616
500,336
421,326
Total Expenses
2,333,466
2,333,466
2,327,133
2,422,209
2,124,300
Net Income from Continuing & Discontinued Operation
-637,324
-637,324
-3,627,535
4,254,257
3,814,229
Normalized Income
293,954
293,954
382,859
403,384
320,557
Interest Income
100,900
100,900
58,000
18,900
18,200
Interest Expense
49,439
49,439
38,114
1,551
21,861
Net Interest Income
51,461
51,461
19,886
17,349
-3,661
EBIT
-800,665
-800,665
-4,666,159
5,450,606
4,939,868
EBITDA
-654,765
-654,765
-4,528,859
5,588,206
5,078,468
Reconciled Cost of Revenue
1,244,316
1,244,316
1,234,919
1,284,449
1,107,739
Reconciled Depreciation
145,900
145,900
137,300
137,600
138,600
Net Income from Continuing Operation Net Minority Interest
-637,324
-637,324
-3,627,535
4,254,257
3,814,229
Total Unusual Items Excluding Goodwill
-1,241,704
-1,241,704
-5,201,549
4,930,695
4,502,154
Total Unusual Items
-1,241,704
-1,241,704
-5,201,549
4,930,695
4,502,154
Normalized EBITDA
586,939
586,939
672,690
657,511
576,314
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-310,426
-310,426
-1,191,155
1,079,822
1,008,482